这家研究公司还发现，2013年投资前估值的中值全面上涨。种子阶段交易上升到惊人的510万美元，而Series A阶段则攀升到了940万美元。与往常一样，最大百分比增幅出现在Series A和Series B（中值为2,710万美元）中，Series C达到6,260万美元（较2012年增长23%），Series D和此后融资阶段为1.052亿美元（较2012年增长了14%）。
种子阶段交易估值最高的行业是医疗设备/用品行业（600万美元），Series A交易估值最高的行业是商业服务（1,200万美元），Series B交易估值最高的是医药/生物技术（2,960万美元）。Series C和Series D+阶段交易估值最高的行业是传媒（分别为9,170万美元和1.88亿美元）。
Is it a startup bubble or a startup boom? Either way, it's growing.
Venture capitalists paid record highs to invest in private companies last year, according to new data from Pitchbook.
The research firm found that median pre-money valuations were up across the board in 2013. Seed-stage deals rose to a whopping $5.1 million, while Series A rounds climbed to $9.4 million. Per usual, the largest percentage jump was between Series A and Series B (median of $27.1 million), while Series C rounds hit $62.6 million (up 23% from 2012) and Series D and later rounds came in at $105.2 million (up 14% from 2012).
The highest seed-stage valuations were in healthcare devices/supplies sector ($6m), while the highest Series A were in commercial services ($12m) and the highest Series B were in pharma/biotech ($29.6m). The highest Series C and Series D+ rounds were in media ($91.7m and $188m, respectively).
In terms of geography, the priciest seed and early-stage deals came out of the Bay Area, while New York took the crown for later-stage transactions.
The only countervailing trend was that only three of every five deals came at a higher valuation than did the company's prior round, with approximately 20% of deals coming in flat. Prior to the financial crisis, Pitchbook reports that around 75% of follow-on rounds were at increased valuations.